ATE253360T1 - Acridine derivate zur verbesserung der oralen bioverfügbarkeit von taxol - Google Patents

Acridine derivate zur verbesserung der oralen bioverfügbarkeit von taxol

Info

Publication number
ATE253360T1
ATE253360T1 AT98947501T AT98947501T ATE253360T1 AT E253360 T1 ATE253360 T1 AT E253360T1 AT 98947501 T AT98947501 T AT 98947501T AT 98947501 T AT98947501 T AT 98947501T AT E253360 T1 ATE253360 T1 AT E253360T1
Authority
AT
Austria
Prior art keywords
taxol
improve
oral bioavailability
acridine derivatives
derivatives
Prior art date
Application number
AT98947501T
Other languages
English (en)
Inventor
Jan H M Schellens
Plesmanlaan
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE253360T1 publication Critical patent/ATE253360T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT98947501T 1997-09-05 1998-09-03 Acridine derivate zur verbesserung der oralen bioverfügbarkeit von taxol ATE253360T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9718903.9A GB9718903D0 (en) 1997-09-05 1997-09-05 Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
PCT/EP1998/005557 WO1999012570A2 (en) 1997-09-05 1998-09-03 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents

Publications (1)

Publication Number Publication Date
ATE253360T1 true ATE253360T1 (de) 2003-11-15

Family

ID=10818634

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98947501T ATE253360T1 (de) 1997-09-05 1998-09-03 Acridine derivate zur verbesserung der oralen bioverfügbarkeit von taxol

Country Status (15)

Country Link
US (2) US6469022B1 (de)
EP (1) EP1009436B1 (de)
JP (2) JP4516688B2 (de)
KR (1) KR100579030B1 (de)
AT (1) ATE253360T1 (de)
AU (1) AU751085B2 (de)
BR (1) BR9812179A (de)
CA (1) CA2302568C (de)
DE (1) DE69819525T2 (de)
DK (1) DK1009436T3 (de)
ES (1) ES2210823T3 (de)
GB (1) GB9718903D0 (de)
PT (1) PT1009436E (de)
TR (1) TR200000586T2 (de)
WO (1) WO1999012570A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964946B1 (en) 1995-10-26 2005-11-15 Baker Norton Pharmaceuticals, Inc. Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
DK0994706T3 (da) * 1997-05-27 2006-03-06 Ivax Research Inc Præparater til oral indgivelse af taxaner og anvendelse deraf
GB9718903D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
GB9812189D0 (en) * 1998-06-05 1998-08-05 Glaxo Group Ltd Methods and compositions for increasing penetration of HIV protease inhibitors
EP1749540B1 (de) * 1999-05-17 2010-10-13 Cancer Research Ventures Limited Zubereitungen zur Erhöhung der Bioverfügbarkeit von oral verabreichten pharmazeutischen Verbindungen
EP1479382A1 (de) * 1999-06-18 2004-11-24 IVAX Research, Inc. Taxane enthaltende orale Pharmazeutische Zusammensetzungen sowie Behandlungsverfahren unter deren Verwendung
WO2001030448A1 (en) * 1999-10-27 2001-05-03 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6887842B1 (en) 1999-11-19 2005-05-03 The Board Of Trustees Of The Leland Stanford Junior University Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug
WO2005007081A2 (en) 2003-05-22 2005-01-27 United Therapeutics Corporation Compounds and methods for delivery of prostacyclin analogs
CN101287457B (zh) * 2004-04-12 2011-11-16 联合治疗公司 Treprostinil用于治疗神经性糖尿病的足部溃疡的用途
US8518022B2 (en) 2004-08-27 2013-08-27 Medimetrics Personalized Drug Delivery, Inc. Electronically and remotely controlled pill and system for delivering at least one medicament
JP2008521794A (ja) * 2004-11-29 2008-06-26 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 少なくとも一の薬剤を輸送するための、少なくとも一のセンサを有する電子制御式の錠剤およびシステム
CN101945613B (zh) * 2008-02-18 2014-08-13 皇家飞利浦电子股份有限公司 为患者用药
US8990018B2 (en) * 2008-03-31 2015-03-24 MEDIMETRICS Personalized Drug Delivery B.V. Method of preparing a swallowable capsule comprising a sensor
EP2303361B1 (de) 2008-06-19 2015-02-25 Medimetrics Personalized Drug Delivery B.V. Kapsel zur abgabe von pulverförmigem medikament in den verdauungstrakt
WO2009156919A1 (en) * 2008-06-25 2009-12-30 Koninklijke Philips Electronics N.V. Electronic pill comprising a plurality of medicine reservoirs
EP2464414B1 (de) 2009-08-12 2013-06-12 Medimetrics Personalized Drug Delivery B.V. Wirkstofffreisetzungsvorrichtung mit komprimierbarem wirkstoffreservoir
CN105164098A (zh) 2013-03-14 2015-12-16 联合治疗公司 曲前列环素的固体形式
US10201552B2 (en) 2013-09-05 2019-02-12 Howard University Method of increasing the bioavailability of an HIV drug
TWI752750B (zh) * 2015-09-30 2022-01-11 香港商慧源香港創新有限公司 口服紫杉烷組合物及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT68856A (en) * 1991-01-11 1995-08-28 Glaxo Lab Sa Acridine derivatives, pharmaceutical compositions comprising the same compouds as effective substances and a process for producing the compounds and the pharmaceutical compositions
US6245805B1 (en) 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
DK0994706T3 (da) * 1997-05-27 2006-03-06 Ivax Research Inc Præparater til oral indgivelse af taxaner og anvendelse deraf
GB9718903D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
EP1749540B1 (de) * 1999-05-17 2010-10-13 Cancer Research Ventures Limited Zubereitungen zur Erhöhung der Bioverfügbarkeit von oral verabreichten pharmazeutischen Verbindungen

Also Published As

Publication number Publication date
GB9718903D0 (en) 1997-11-12
US6469022B1 (en) 2002-10-22
AU9439498A (en) 1999-03-29
CA2302568C (en) 2010-06-22
US6803373B2 (en) 2004-10-12
KR100579030B1 (ko) 2006-05-12
BR9812179A (pt) 2000-07-18
WO1999012570A3 (en) 1999-08-19
JP2001515872A (ja) 2001-09-25
KR20010023670A (ko) 2001-03-26
PT1009436E (pt) 2004-03-31
DE69819525T2 (de) 2004-09-23
JP4516688B2 (ja) 2010-08-04
CA2302568A1 (en) 1999-03-18
WO1999012570A2 (en) 1999-03-18
TR200000586T2 (tr) 2000-09-21
DK1009436T3 (da) 2004-03-08
DE69819525D1 (de) 2003-12-11
US20030013731A1 (en) 2003-01-16
AU751085B2 (en) 2002-08-08
ES2210823T3 (es) 2004-07-01
JP2010059185A (ja) 2010-03-18
EP1009436A2 (de) 2000-06-21
EP1009436B1 (de) 2003-11-05

Similar Documents

Publication Publication Date Title
ATE253360T1 (de) Acridine derivate zur verbesserung der oralen bioverfügbarkeit von taxol
PT1109812E (pt) Pirrolobenzodiazepinas
DE60032780D1 (de) Tetrahydroquinolin-derivate
DE60004317D1 (de) Salze von Sulfonium-Verbindungen
ATE263147T1 (de) Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
CY1109276T1 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
DE122004000018I2 (de) 4"-substitutierte-9-deoxo-9a-aza-9a-homoerythromycin a derivate
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
DE69839131D1 (de) Arylkondensierte azapolycyclische derivate
DK0977741T3 (da) Substituerede phenylderivater, deres fremstilling og anvendelse
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
EP1191933A4 (de) Nasale verabreichung von apomorphin
FI963169A0 (fi) Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia
DE58904761D1 (de) Chirale derivate des 1,2 -difluorbenzols.
IT1295933B1 (it) 2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
DE69611758D1 (de) N-1-carbocylalkyl derivate von lsd
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
DE69908614D1 (de) Herstellung von n-substituierten-hydroxycycloalkylamin-derivaten
ATE254929T1 (de) Oralverabreichbare lösung von prucaloprid
SE9701438D0 (sv) A new process
FI971831A0 (fi) Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina
NO20013715L (no) Karbamatderivater av diaryl 1,3,4-oksadiazolon
BR0012592A (pt) Composto, uso dos compostos, combinação, e, preparação farmacêutica para uso oral ou parenteral
ECSP992932A (es) Derivados de epotilona 12,13- modificados

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1009436

Country of ref document: EP